The present application relates to the in-vivo imaging arts. It finds particular application with workflow and software processing in connection with small animal imaging in a research environment, and will be described with particular reference thereto. It is to be appreciated that the present application also finds use in other clinical and research settings, such as research with human subjects.
Presently available imaging scanners are not equipped with standardized equipment and techniques that support automated and scientifically rigorous workflow suited to the testing of medical hypotheses. Pre-clinical imaging helps to bridge the gap between medical treatment ideas that have not yet been proven reliable and application in human treatment. Pre-clinical animal imaging research can be used to define the conditions and end points for clinical trials. Specifically, pre-clinical in-vivo small animal imaging provides the capability to visualize and quantify metabolic activity, cell proliferation, apoptosis, receptor status and immunoreactions, angiogenesis, and hypoxia, among other relevant biological processes. This is done by indirectly measuring gene expression, enzyme activity, receptors and transporters, and regional concentrations of molecules through a variety of means, most commonly using emission imaging techniques with radio-labeled tracers.
This research is characterized by curiosity and/or by hypothesis driven programs often supported by grants to either discover or explore new insights into biological processes. As such, device characteristics such as sensitivity and spatial resolution are at a premium, particularly when viewed against a continual need to visualize smaller and smaller structures and processes. Additionally, the need for quantification of these processes increases as the research moves from describing systems to measuring systems. This work is primarily conducted in academic medical centers. As such, the knowledge of the community advances through literature, conferences, and symposia. Typically, small scale applications are also pursued for promising research findings. Success criteria include the ability to clearly and effectively demonstrate and expand understanding, whether it results in direct commercial activity or not.
A more specific expression of biological research is the systematic discovery and development of biomarkers, drugs, and therapies that will ultimately be translated from animal models to humans should they prove promising during pre-clinical studies. Distinguishing this area from the more varied general biological area is the need to follow standardized, calibrated processes capable of supporting rigorous regulatory filings. As such, this work is typically (though not exclusively) conducted in commercial pharmaceutical companies and/or instrumentation companies as they seek to discover, develop, and ultimately commercialize drugs and therapies for economic return rather than only build the general knowledge into the processes.
Quantification is important for reliable evaluation of the acquired data. Without the information on tracer concentration in physical, absolute units, different tracers cannot be compared with each other in an objective manner in the context of tracer development. Also, the quality of diagnostic information extracted from the acquired images depends crucially on the quantifiability of the data. Especially from small animal imaging, a variety of considerations such as, for example, partial volume effects play an important role and should be corrected in order to obtain meaningful concentration values. These effects may be mitigated with single-imaging mode design and/or corrections, or through using complementary modality data such as (but not limited to) anatomical information from a CT scan, which can be helpful in this context.
Quantification is valuable in the marketplace. Software tools dealing with partial volume and motion correction, and the like are available, and valuable for reliable quantification. Animal imaging plays an important role in the process of tracer development and validation by reducing the amount of time and effort that has to be spent for evaluating tracer properties. With in-vivo imaging, it is possible to perform a serial analysis of the same animal over a period of time and thus study, for example, the bio-distribution of the tracer over a long time span. Without imaging, the same study would involve many animals, which would have to be sacrificed at various time points to measure the tracer distribution with in-vitro methods. Moreover, by applying such techniques as pharmacokinetic modeling, it is possible to assess multiple biological parameters at once in one imaging procedure.
Pharmacokinetic modeling of pharmacodynamics allows the simultaneous assessment of multiple biological and molecular parameters at once. Since the distribution of the tracer in the animal over the course of time is a dynamic process, static imaging only contains limited information compared to the analysis of dynamic sequences, which provides access to the rate constants governing the kinetic processes.
Pre-clinical applications to support this activity can be summarized as providing users the capability to perform studies of varying scope, each level highlighting requirements or focus areas for the device;
A snapshot measurement on a single subject, e.g., uptake;
Time activity during 1-5 half lives of the radio labeled marker;
A longitudinal study of a single subject across multiple imaging sessions;
A group study with multiple subjects in the same laboratory; and
Population analysis across multiple distributed studies and/or methodologies.
The levels apply most directly to the discovery and development processes for drugs and biomarkers. Software applications implementing these study types is important because doing so facilitates standardization leading to higher quality, more reproducible studies that replace time consuming and error prone manual methods or custom programming that is particularly difficult given the data volume associated with this work. Important standardization should be driven by the instrumentation rather than relying on individual principal investigators.
The present application provides a new and improved small animal handling, imaging, and research data analysis technique that overcomes the above-referenced problems and others.
In accordance with one aspect, an in-vivo imaging system is provided. At least one imaging modality for acquiring in-vivo imaging data of a subject in an imaging region of the imaging device. A reconstruction processor reconstructs raw data into an image representation. A preparation module provides space where subjects are prepared for imaging in the imaging modality. A research workstation provides a user with an electronic interface to the imaging modality.
In accordance with another aspect, a method of in-vivo imaging is provided. A study is designed for execution on an in-vivo imaging system. Desired data mining and computational bioinformatics activities are selected complement the imaging study. Imaging data is acquired and processed. The processed imaging data is quantified. A statistical analysis is performed on the processed imaging data and/or with results from the computational activities. Then, the statistical analysis is reported in a form that the user chooses.
In accordance with another aspect, a research workstation for designing an in-vivo imaging study is provided. The workstation includes a study design portal for creating and defining the study. A user can select data pertinent to the study from resources to which the workstation has access at a data mining portal. The user can select available tools from image acquisition, reconstruction, and/or image processing portals. The user can select available tools from a pre-defined set of tools and clinical packages at a quantification portal.
The user can select at least one of a pre-defined post processing analysis and an ad-hoc post processing analysis at a statistical analysis portal. A reporting portal allows a user to customize a data reporting method.
In accordance with another aspect, a method of designing a study is provided. A hypothesis capable of being tested in an in-vivo imaging environment is formulated by a user. A study design workflow routine is initiated on a workstation computer. A relationship between imaging and computational methods is specified. Parameters of the study are specified. When the study is designed, a confidence level in the study design is obtained by requesting construction of a model of likely results of the study.
One advantage lies in improved reproducibility of studies.
Another advantage lies in greater flexibility for a user to design and execute studies.
Another advantage lies in access to existing studies and information databases.
Another advantage lies in the ability to se standardized protocols for imaging studies.
Another advantage lies in the structured post processing of imaging data to maximize the statistical confidence of the results.
Another advantage lies in the ability to utilize the reported results in regulatory filings that establish the efficacy of novel diagnostics and therapeutics.
Still further advantages of the present invention will be appreciated to those of ordinary skill in the art upon reading and understand the following detailed description.
The invention may take form in various components and arrangements of components, and in various steps and arrangements of steps. The drawings are only for purposes of illustrating the preferred embodiments and are not to be construed as limiting the invention.
With reference to
With reference to
With reference to
A single animal capsule 14 can support several different bed 16 configurations. One capsule 14 can accommodate up to two (2) rat beds 16, and alternatively, one capsule 14 can accommodate a larger plurality, e.g. four (4), mouse beds 16. Apart from a bed mount, each of the capsule interfaces 24 also provides one or more sockets connected with the measurement sensors 20, a fluid interface for air and anesthesia, and the like. The beds 16 can be either profiled beds or flat pallets. For increasing heating efficiency, it is preferable that separate and as small as possible cylinders 18 be used around each of the animals instead of one large cylinder 18 covering all the animals, although the latter embodiment is by no means unviable. The cylinders 18 are preferably easily removable. Holes are also provided, through which it is possible to insert or pull out catheters for isotope injection and/or optional measurements and physical interactions.
A flat pallet bed type allows animal technicians to work with non-standard measurements or with non-commonly used animals or animal configurations. The technicians can freely place different animals of different sizes and weights. The nosecone 22 on the pallet bed 16 preferably is interchangeable to accommodate different sizes of animals. The nosecone 22 is preferably radio-translucent and tightly covers the animal's head. Additionally, the nosecone 22 can be removed, e.g. if an injected anesthesia is used. The pallet bed 16 is equipped with holes at each side for mounting motion restraints.
In another embodiment, the bed 16 is a form fitting, profiled bed. The profiled bed 16 preferably comes in a few types, each configured to accommodate different animal categories (rats, mice) and sizes (small, medium, large). The bed curves allows for easy and repeatable animal positioning, both with the same subject in temporally remote scans, or with different subjects. Motion restraints are integrated into the bed to prevent re-arrangement of the subject during or between scans. Restraints integrated with the bed 16 are also contemplated in lieu of traditional taping and un-taping.
ECG and respiration probes 20 are preferably integrated with the bed 16. Alternately, sensors can be applied to the subject manually. SpO2 and heating elements may also be parts of the bed 16. Position marks on the bed (i.e. ruler-like markings) assist in reproducing positions when mounting subjects to the bed 16. Given that exact repositioning is desirable in brain imaging, a stereotactic frame may be included. To allow access to the subject without disturbing the subject's position while it is fixed to the bed 16, it is preferable to leave the animal's tail, legs, and eyes accessible while the animal is fixed to the bed 16. It is desirable to autoclave elements that are in contact with animals, so those particular components are preferably resilient to high temperature steam cleaning and disinfection. The beds are independently removable to facilitate access to subjects in multi-animal configurations. With rat and mouse subjects, heated tail holders are preferable because they help prevent tail veins from contracting in a cold environment and altering blood flow rates. Absorbent materials can be included to handle excretion during imaging sessions; the bed design can accommodate disposable materials, or they can be integrated into the bed 16. The bed 16 can be designed with all or most of desired probes embedded into the bed 16. Alternately, the bed can be designed with all probes flexible enough to be placed wherever they are required by the operator. The integrated sensors are useful for standard imaging, specifically where throughput is an issue. External probes can be used in, e.g., complex research scenarios, where it is more important to execute given scenario with maximum accuracy. Although the animal preparation and imaging modules are contemplated and shown side by side, animal preparation and imaging may be located in separate rooms.
With reference again to
The modules can be arranged side by side in a parallel fashion, as shown in
In the embodiment of
Having thus described hardware and modularity of the system, the application now turns to a typical workflow process of imaging a small animal subject. First, the animal is brought to the facility. In the past, animals involved in a study would typically need to be sacrificed in order to acquire ex vivo measurements, essentially freezing uptake characteristics at a point in time. In the present system, such sacrifices are not necessary, so the same animals can be imaged many times over the course of the study. Thus, animals are typically kept on-site, but it is contemplated that they can be brought in from off site. The animal is brought to the scan room and anesthetized. As mentioned previously, this is done with coarse anesthesia in the induction chamber. Once the animal is anesthetized, the animal is positioned and affixed to the imaging bed 16. In addition to positioning the region of interest of the animal, positioning the animal also includes positioning the animals head securely in the nosecone 22 for the automatic, continual delivery of anesthesia. At this time the sensors 20 are attached to the subject animal. Once the animal is positioned on the bed 16 the cover 18 is placed over the animal and the capsule 14 is attached to one of the docking ports 29.
Next, the user calibrates 40 the system. This involves both a software calibration and a hardware calibration, such as X and Y axis zeroing. Once the scanner is calibrated, the positioner 26 relocates the capsule 14 from the docking port 29 on the preparation module 28 to the docking port 29 on the scanning module 12. Once the capsule has been properly positioned in the scanning module, the scan is initiated. While the scan is proceeding, the AMA 38 monitors environmental factors of the capsule 14 and vital signs of the subject, and continuously supplies anesthesia to the subject. Subject monitoring allows the user to eliminate physiological variables to the greatest extent possible. By controlling the physiological variables, study design confidence is enhanced as results will be more readily reproducible. Put another way, fluctuations in physiological variables can taint an otherwise sound study, so it is desirable to control these variables as much as possible.
Once the scan is completed, the animal is removed from the capsule and placed in the post-anesthesia chamber to wake up. Here the AMA 38 monitors the temperature of the chamber. When the animal regains consciousness, it is transferred back to its living environment. The imaging scan can then be processed and integrated into the user's overall clinical study.
To facilitate creation of a study, the system includes a research workstation 30. The workstation 30 includes a computer that controls main system functions and provides an interface for a user to work with the image data. The research workstation 30 includes acquisition control to allow starting, pausing, resuming and stopping an image acquisition and showing status and progress info on the acquisition. The research workstation 30 also interfaces with the AMA 38 in order to display vital signs for multiple animals scanned across several modalities and stages of animal preparation on the workstation. Additionally, acquisition control and a reconstruction user interface may reside in whole or in part on the research workstation 30. Multimodality function is included on the research workstation 30 such as PET-CT non-rigid registration. In such a situation, interfacing with a CT Acquisition control can to be done via the research workstation 30. It is preferable that the research workstation 30 provides a migration path for all applications of the system 10 to use a common platform for infrastructure services and operation. Naturally, the research workstation 30 can be upgraded as new preparation techniques, scanning techniques, software, hardware, and the like become available.
Studies conducted for the purpose of research are often hypothesis driven. A technician or clinician may have an idea and run with it. Perhaps results of one study make technicians ask questions they would not have otherwise asked. Other studies may not be researching entirely new ideas, but bolstering the validity of already-existing hypotheses. In either case, it is beneficial for a technician to have the ability to design and modify imaging studies. This includes both developing new aspects of studies and calling upon known methods and techniques to complement new ideas.
With reference to
Further to study design and management, the research workstation 30 provides a visual user study design interface 33 for assessing study approaches, steps, subject quantities, statistical analysis and other data processing results, and the like. This allows the user to achieve a specified level of confidence given accumulated system accuracies and inaccuracies, as well as specifying a relationship between local imaging and computational methods such as data mining and bioinformatics. The research workstation 30 allows the user to set up complex processes graphically, with the ability to select sequences of steps to conduct a study. The user can designate various widely accepted study types, ranging from loosely structured pilot studies to increasingly rigorous and controlled studies.
The study design capability works by providing a capability for the user to “drag and drop” blocks that represent the various data import, acquisition, processing, quantification, visualization, analysis, and reporting capabilities onto a palette representing the image and data flow according to their needs. The workstation 30 provides a library of blocks that provide a combination of established and novel steps. Once a block is dragged onto the palette, the user is allowed to set “properties” of the block that configure it for the particular study and account for the user defined interconnections that are desired. Calculators to assess system accuracies and confidence levels are provided by the system, along with means to determine a number of subjects or imaging sessions required to achieve a predictive statistical significance with respect to a hypothesis are provided. Results attained from the studies, settings, indexing, data handling, control, and option settings are all associated with the named study and can be recalled for later use. In this manner, a user can simply have the research workstation 30 recall a study that worked well and adapt selected parameters or blocks to create a new study rather than defining a new study from scratch.
The research workstation 30 also includes a data mining/bioinformatics design interface, or portal. This subscreen allows the user to access third party search engines 35a or internal proprietary information applications to access organ models 35b and disease models 35c, population databases 35d, subject specific data 35e, IP data 35f, quantification data 35g, report data 35h, biobanks 35i, the electronic patient chart (EPR) 35j and other knowledge databases 35k. Such information may include editable templates, STL files, normals, collectives, and the like. This aspect provides a place for commercializing informatics research applications that complement standard imaging. Incidentally, after a study has been created and tested, it can be integrated back into the various knowledge databases 35j for future reference.
Another design interface or portal available to the user includes choices concerning image acquisition and reconstruction 37. The research workstation 30 is used to create the study, to register animal data and to invoke a workflow. The research workstation 30 supports the operator workflow in visualizing protocols, providing acquisition control and status and providing images for reviewing. The research workstation 30 has a large, high resolution display connected. This display supports sensitive subject control and provides easy access to large amounts of information. This includes protocol selection and modification. Additionally, the user is able to manage the Digital Imaging and Communications in Medicine (DICOM) 58 format as well as other native imported image formats. Instrument calibration and accuracy data can be transported in private tags. Outside data that does not have instrument calibration and accuracy tags can be hand entered upon a prompt by the research workstation 30. Data can then be output to a picture archiving communication system or PACS 60.
At an image processing workflow design interface 39 the user can select from a variety of post-acquisition image adjustments and enhancements. In one embodiment, this subscreen presents a graphic user interface for registration of various types, surface and volume rendering, model-based segmentation, visualization, fusion, and the like. Additionally the user has the option to select corrections, such as partial volume correction and local motion correction. Data can be represented as a “transform,” from multiple inputs to multiple outputs, including displayable portions (e.g. an image) and non-displayable portions (e.g. a deformation field). Also, the image processing subscreen is a convenient place to include longitudinal and group study protocols 56.
The research workstation 30 also includes a quantification design interface 41. At this point, the user can select standard uptake values (SUVs), pharmacokinetics, tools associated with specific organ systems and/or disease processes such as cardiology, neurology, oncology, bone densitometry, neo-vascularization, as well as other packages. Generally, the user has the option to select existing packages that have been tested and re-used often, as well as packages that are less well known but on their way to becoming accepted packages. It is also preferable that the user have the flexibility to create packages, if desired. Some analysis is generally relevant to the preclinical domain whereas in many cases the packages may be early versions that will ultimately be validated for clinical use. In this way, the system aids translation of capability from animal models to human models.
In a statistical analysis workflow design interface 43, the user can plan and execute analysis of the study that they have previously designed. Here, the user can, for example, utilize Bayesian confidence calculations for hypothesis evaluation 47. Hypothesis evaluation 47 includes both study design 33 and statistical analysis 43. Several automated evaluation frameworks are available in well know study formats, depending on what the user hopes to gain from the data. This subscreen also includes access to statistical calculations for ad-hoc post scan analyses, and is not restricted to pre-designed studies. This way, if the user suspects that there may be some trend or association in the data, they can design their own analyses to investigate it.
Finally, the user has several options when it comes to reporting data. At a reporting design interface 45, charts, graphs, literature summaries, standard FDA reports, and the like are available to the user for reporting their study. Of course, the user can also custom design a reporting method that lends itself to illustrating the instant study. Preferably, the workstation 30 also includes hardware modeling functionality that allows a user to design orientations and arrangements of the hardware the user has at their disposal. As each research setting will have different capabilities and constraints (funding, physical space, etc.) each setting will have different hardware available to it. The user can tell the system what hardware it has available and then design an arrangement to aid in workflow and subject processing. With mobile modular modalities, the user has the flexibility to arrange the modalities to best facilitate execution of his or her hypothesis testing. The system can also take the hardware arrangement into account when evaluating the study, such as identifying potential bottlenecks, problems with keeping the subjects under anesthesia too long, and the like.
Elements of the system and their relationship to each other are shown in
A server 34 processes data gathered by the scanner 12 and also provides control, reconstruction processing, and support for programmatic interfaces to the acquisition system. The modality controller 36 controls local modality functionalities and keeps track of the studies defined for the modality. These include the AMA subsystem 38, the positioner 26, docking 29, the user interface 32, and a positioning laser 42. The controller 36 also provides input from the interface 32 of the modality 12 to the research workstation computer 30. The controller 36 allows selection of a study when a capsule 14 is attached. It retrieves protocol information for the selected study and allows updating of the selected study. When an acquisition screen at the touch screen 32 is chosen, it activates the study at the research workstation 30, causing the protocol to be loaded into the acquisition controller 12 by the research workstation 30.
The AMA subsystem 38 implements vital signs monitoring (temperature pulse rate, blood pressure, ECG, etc.), anesthesia and waste gas scavenging, and temperature control of the subject or subjects. The AMA subsystem 38 is physically connected to the animal capsule 14 with leads for the monitoring probes 20, a heater for temperature control, and tubes to carry anesthesia and waste gas.
A reconstruction processor 44 is used as a compute resource for reconstruction. The reconstruction processor 44 is connected to the server 34 via a network connection, such as a second thin-net connection that supports raw data handling, reconstruction control, and image transfer handling. Additional modalities can be introduced in the system 10, and in this event, the reconstruction processor 44 can also handle those image formation tasks. In such a case, the reconstruction processor 44 receives raw image data via a proprietary high-speed serial link. The reconstruction processor 44 is connected to the server 34 via a 1 GB thin-net connection, for example, which in turn supports a higher-level programmatic interface for CT reconstruction protocols and image transfer. The server 34 also uses this interface to provide reconstruction control via a programmatic interface to the reconstruction processor unit 44. Preferably, the reconstruction processor 44 includes five servers, but can include more or less as processing tasks demand. The research workstation 30 includes tools as described herein, and suitable rapid prototyping environment software.
A positioner control subsystem 46 interfaces to the modality controller 36, e.g. via an Ethernet connection. Via this connection, movement commands are issued and status and position information is returned. The positioner control 46 is responsible for control of the position of the subject positioner 26. Motion of the positioner 26 is executed through the modality controller 36 and the position controller 46. The modality controller 36 implements the interfaces that perform selected bed motions. The positioner controller 46 translates this into servo commands. A high speed router 48 connects the research workstation 30, the reconstruction processor 44 and the server 34 to the imager 12. The router 48 is preferably a 1 GB intelligent router that allows isolation of the acquisition sub-net(s) from a department or external network 50. The imaging modality 12, research workstation 30, server 34, reconstruction processor 44, and router 48 can be thought of collectively as an acquisition sub-net 51. Logically, the acquisition sub-net 51 links acquisition control (located within the given modality), the server 34, the research workstation 30, and the reconstruction processor 44. This interface carries acquisition control commands from the research workstation 30 to imaging acquisition 12 and the server, allows the research workstation 30 to request subject positioner 26 motion, and provides the path by which raw imaging data is transferred from acquisition 12 to the server 34 and reconstruction processor 44. The intelligent router 48 is used to isolate this logical connection. The connection to the research workstation 30 also supports transfer of minimally processed images to the server platform 34 and to external (i.e. department network) devices 50.
A power supply 52 subsystem provides various AC and DC voltages for the components. Emergency shutoff (E-stop) circuitry 54 cuts electrical power when the circuit is interrupted. When the E-stop circuitry 54 is activated, the power supply will switch to a safe mode, e.g., high voltage and motion control power can be switched off, while computing elements may remain operational. The modality controller 36 is able to read and control the status. It is contemplated that the power system 52 can be factory configurable to accept 120V or 230V AC. Additionally, the power supply will contain a power adaptation module. This module will output 230V in order to supply modules that require higher voltages, such as the reconstruction processor 44.
The Docking Interface module 29 is responsible for allowing accurate docking of the animal capsule 14 to the positioner 26. Furthermore, the module 29 is responsible for making robust electrical and pneumatic connections. The docking interface can be electrically controlled by means of an actuator. Generally, the acquisition module 12 and the docking station 28 are encased in a frame that preferably minimizes the weight and maximizes the rigidity of the system. Additionally, the frame should be virtually transparent to radiation events, so it can encase the bore of the imaging device. Fiberglass is an exemplary frame material. Preferably, a touch screen 32 or other local user interface is included for controlling the positioner 26, displaying AMA data, and to aid in subject positioning. The positioner controller 46 receives motion commands from the touch screen 32 via software also running on the modality controller 36 to perform bed motion. The touch screen 32 provides part of the modality human interfaces. Software for the touch screen 32 runs on the modality controller 36 and interfaces with the AMA 38, motion control and acquisition info components, also running on the modality controller 36. The position of the local user interface 32 is dictated by functional considerations, such as objects typically in or around the bore of the device during imaging, and the like. Preferably, the frame is equipped with cover-switches integrated into the E-stop circuitry to switch of power in case the covers are opened.
The invention has been described with reference to the preferred embodiments. Modifications and alterations may occur to others upon reading and understanding the preceding detailed description. It is intended that the invention be constructed as including all such modifications and alterations insofar as they come within the scope of the appended claims or the equivalents thereof.
This application is a continuation of PCT application number PCT/US2007/069596 filed May 24, 2007 which claims the benefit of U.S. provisional application No. 60/803,755 filed Jun. 2, 2006, which is incorporated herein by reference.
Number | Name | Date | Kind |
---|---|---|---|
5099792 | Cannon et al. | Mar 1992 | A |
6458081 | Matsui et al. | Oct 2002 | B1 |
6574304 | Hsieh et al. | Jun 2003 | B1 |
6585647 | Winder | Jul 2003 | B1 |
6983753 | Lenhard et al. | Jan 2006 | B1 |
7158692 | Chalana et al. | Jan 2007 | B2 |
7170974 | Groh et al. | Jan 2007 | B2 |
7395117 | Mazar et al. | Jul 2008 | B2 |
7603165 | Townsend et al. | Oct 2009 | B2 |
7792343 | Pekar | Sep 2010 | B2 |
7865226 | Chiodo | Jan 2011 | B2 |
20030092980 | Nitz | May 2003 | A1 |
20030220565 | Mesaros et al. | Nov 2003 | A1 |
20040071320 | Pfister | Apr 2004 | A1 |
20050113961 | Sabol et al. | May 2005 | A1 |
20060030768 | Ramamurthy et al. | Feb 2006 | A1 |
20060058606 | Davis et al. | Mar 2006 | A1 |
20060291710 | Wang et al. | Dec 2006 | A1 |
20070025606 | Gholap et al. | Feb 2007 | A1 |
20070049815 | Sanjay-Gopal et al. | Mar 2007 | A1 |
20070113194 | Bales et al. | May 2007 | A1 |
20070238946 | Chiodo | Oct 2007 | A1 |
20080077025 | Delgado-Herrera et al. | Mar 2008 | A1 |
20090080600 | Keller et al. | Mar 2009 | A1 |
Number | Date | Country |
---|---|---|
2006020896 | Feb 2006 | WO |
Entry |
---|
Dazai et al. (Multiple Mouse Biological Loading and Monitoring System for MR, Magnetic Resonance in Medicine 52:709-715, 2004). |
Milad et al., “Fear extinction in rats: Implications for human brain imaging and anxiety disorders”; Biological Psychology; vol. 73, pp. 61-71, Feb. 13, 2006. |
Number | Date | Country | |
---|---|---|---|
20090043172 A1 | Feb 2009 | US |
Number | Date | Country | |
---|---|---|---|
60803755 | Jun 2006 | US |
Number | Date | Country | |
---|---|---|---|
Parent | PCT/US2007/069596 | May 2007 | US |
Child | 12195627 | US |